General Information of the Compound
| Compound ID |
CP0157151
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
9,10-dihydroanthracene(DHA), 1a
Show/Hide
|
||||||||||||||||||
| Synonyms |
9-(Aminomethyl)-9,10-dihydroanthracene
C-(9,10-Dihydro-anthracen-9-yl)-methylamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H15N
|
||||||||||||||||||
| Molecular Weight |
209.292
|
||||||||||||||||||
| Canonical SMILES |
NCC1c2ccccc2Cc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H15N/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-8,15H,9-10,16H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
GEICAQNIOJFRQN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01492, 5-hydroxytryptamine receptor 2A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT05193, 5-hydroxytryptamine receptor 2C
Protein ID: PT00867, D(2) dopamine receptor
Protein ID: PT01607, Sodium-dependent noradrenaline transporter
Protein ID: PT01609, Sodium-dependent serotonin transporter
Clinical Information about the Compound